H-1B sponsorship profile: i3 Pharmaceuticals, LLC. Across U.S. Department of Labor LCA disclosures, i3 Pharmaceuticals, LLC filed 10 Labor Condition Applications covering 10 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 80% (8 certified of 10 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on i3 Pharmaceuticals, LLC’s H-1B petitions range from $58,822 at the low end to $150,000 at the high end, with a petition-weighted average of $95,536. That range reflects the mix of occupations the company sponsors, led by Sr. Research Scientist I (1 petitions at $82,514 avg), followed by Senior Research Scientist II and Senior Research Scientist I. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. i3 Pharmaceuticals, LLC is headquartered in Warminster, PA under NAICS code 325412, and places H-1B workers across 1 state, most heavily in PA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where i3 Pharmaceuticals, LLC ranks. By H-1B petition volume, i3 Pharmaceuticals, LLC is #16,610 of 119,880 employers nationally and #510 of 3,282 employers headquartered in PA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.